Shares of AdvanSix Inc. (NYSE:ASIX - Get Free Report) traded down 0.6% during mid-day trading on Tuesday . The stock traded as low as $31.75 and last traded at $32.16. 24,451 shares were traded during mid-day trading, a decline of 83% from the average session volume of 141,285 shares. The stock had previously closed at $32.34.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on ASIX shares. StockNews.com downgraded shares of AdvanSix from a "buy" rating to a "hold" rating in a research note on Tuesday, November 19th. Piper Sandler upped their target price on AdvanSix from $35.00 to $39.00 and gave the stock an "overweight" rating in a report on Friday, November 8th.
Check Out Our Latest Stock Report on AdvanSix
AdvanSix Stock Performance
The company has a quick ratio of 0.62, a current ratio of 1.34 and a debt-to-equity ratio of 0.28. The stock's fifty day moving average is $29.99 and its two-hundred day moving average is $27.12. The firm has a market capitalization of $851.89 million, a price-to-earnings ratio of 22.81 and a beta of 1.69.
AdvanSix Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be issued a $0.16 dividend. The ex-dividend date is Tuesday, November 12th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.01%. AdvanSix's payout ratio is 45.39%.
Insider Activity at AdvanSix
In other news, CEO Erin N. Kane sold 5,000 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $30.28, for a total value of $151,400.00. Following the transaction, the chief executive officer now directly owns 522,795 shares of the company's stock, valued at $15,830,232.60. This represents a 0.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christopher Gramm sold 2,435 shares of AdvanSix stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $32.00, for a total transaction of $77,920.00. Following the sale, the insider now directly owns 43,463 shares of the company's stock, valued at $1,390,816. The trade was a 5.31 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,418 shares of company stock worth $411,626. Insiders own 5.60% of the company's stock.
Institutional Investors Weigh In On AdvanSix
Large investors have recently added to or reduced their stakes in the stock. Boston Partners acquired a new stake in shares of AdvanSix during the 1st quarter worth $702,000. First Eagle Investment Management LLC increased its holdings in shares of AdvanSix by 33.0% during the second quarter. First Eagle Investment Management LLC now owns 611,077 shares of the company's stock worth $14,006,000 after buying an additional 151,470 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of AdvanSix by 5.4% during the 2nd quarter. American Century Companies Inc. now owns 593,834 shares of the company's stock valued at $13,611,000 after acquiring an additional 30,500 shares in the last quarter. Deprince Race & Zollo Inc. increased its holdings in AdvanSix by 45.2% in the 2nd quarter. Deprince Race & Zollo Inc. now owns 259,824 shares of the company's stock worth $5,955,000 after purchasing an additional 80,915 shares in the last quarter. Finally, Point72 DIFC Ltd bought a new position in AdvanSix in the second quarter valued at about $34,000. Institutional investors and hedge funds own 86.39% of the company's stock.
About AdvanSix
(
Get Free Report)
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AdvanSix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.
While AdvanSix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
